Calcium Silicate

Calcium silicate is an inorganic mineral compound composed of calcium and silicon dioxide that acts as a bioactive material by releasing calcium and silicate ions to stimulate hydroxyapatite formation and hard tissue mineralization. Its primary mechanism involves activating dentinal bridge formation and supporting cellular regeneration in dental and bone tissue applications.

Origin & History

Calcium silicate is a synthetic inorganic compound (primarily Ca₂SiO₄) classified as a bioceramic material, manufactured through industrial synthesis by mixing calcium oxide and silicon dioxide under high heat. It is formulated into premixed cements, sealers, or powders specifically for dental and endodontic applications rather than originating from biological sources.

Historical & Cultural Context

Calcium silicate has no traditional medicine history or ethnomedicinal use. It is a modern bioceramic material specifically developed for contemporary dentistry and endodontic procedures, representing an advancement in synthetic biomaterials rather than a historically used substance.

Health Benefits

• Dental pulp preservation: 76.6-97.1% success rates in pulpotomy procedures for primary and permanent teeth (moderate GRADE certainty, meta-analysis of 14 RCTs)
• Root canal treatment success: 84-90% success rate at 1-year follow-up when used as endodontic sealer (non-randomized trial)
• Enhanced tissue healing: Promotes faster healing and reduced inflammation in dental applications through biocompatibility and mineralization stimulation
• Antibacterial properties: Demonstrates antimicrobial activity for up to 7 days post-application in dental procedures
• Cardiac protection potential: Silicate ions from calcium silicate extract reduced cardiomyocyte hypertrophy in mouse models (preliminary evidence)

How It Works

Calcium silicate releases Ca²⁺ and SiO₄⁴⁻ ions upon contact with physiological fluids, raising local pH to 12–12.5, which precipitates calcium hydroxide and triggers hydroxyapatite nucleation on the material surface. The silicate ions upregulate osteocalcin and bone morphogenetic proteins (BMPs), stimulating odontoblast and osteoblast differentiation for tertiary dentin and bone matrix synthesis. Additionally, the alkaline microenvironment created by calcium ion release exhibits antibacterial activity by disrupting bacterial cell membranes, contributing to its effectiveness as an endodontic sealer.

Scientific Research

A 2025 meta-analysis of 14 RCTs (PMID: 41091272) found calcium silicate-based materials achieved high success rates in dental pulpotomies with no significant differences versus comparators like MTA. A 2023 RCT (PMID: 37660882) involving 153 primary molars demonstrated non-inferiority of calcium silicate formulations to traditional MTA, while a multicenter RCT (PMID: 40653154) compared calcium silicate sealers versus resin sealers for postoperative outcomes.

Clinical Summary

A meta-analysis of 14 randomized controlled trials (moderate GRADE certainty) demonstrated 76.6–97.1% success rates for calcium silicate-based cements in pulpotomy procedures for both primary and permanent teeth. A non-randomized clinical trial reported 84–90% root canal treatment success at 1-year follow-up when calcium silicate was used as an endodontic sealer, comparable to established benchmarks. Evidence for systemic supplementation applications remains limited, with most robust data concentrated in dental and orthopedic biomaterial research rather than oral supplement trials. Overall, the evidence base is strongest for dental clinical applications and weaker for broader systemic health claims.

Nutritional Profile

Calcium silicate (CaSiO₃) is an inorganic mineral compound, not a nutritional substance. It is primarily used as an industrial and biomedical material rather than a dietary source of nutrients. Key compositional details: • Calcium content: approximately 34.5% by molecular weight (Ca from CaSiO₃, MW ~116.16 g/mol), however this calcium is largely biologically unavailable for nutritional absorption when ingested as the intact mineral. • Silicon content: approximately 24.2% by weight as elemental silicon (present as silicate SiO₃²⁻); orthosilicic acid release from calcium silicate in aqueous/physiological environments is minimal and poorly characterized for dietary bioavailability. • No macronutrients (zero protein, fat, carbohydrates, or fiber). • No vitamins or organic bioactive compounds. • Food-grade calcium silicate (E552) is used as an anti-caking agent in powdered foods at concentrations typically ≤2% by weight (FDA 21 CFR 172.410); at these trace levels it contributes negligible nutritional calcium (<5 mg Ca per typical serving). • Bioavailability notes: Calcium silicate is practically insoluble in water (solubility ~0.01 g/100 mL at 25°C), resulting in extremely poor gastrointestinal absorption of both calcium and silicon ions. The calcium is not ionically dissociated under gastric pH conditions to any nutritionally meaningful degree, making it vastly inferior to dietary calcium sources such as calcium carbonate or calcium citrate. • In biomedical/dental applications (e.g., mineral trioxide aggregate, Biodentine), calcium silicate releases Ca²⁺ and OH⁻ ions in situ, creating a localized alkaline environment (pH ~12.5) that promotes hydroxyapatite formation and biomineralization — this is a therapeutic property, not a nutritional one. • The EFSA and FDA classify food-grade calcium silicate as GRAS (Generally Recognized As Safe) with an acceptable daily intake not specified due to its inert nature and negligible absorption. • Trace impurities may include aluminum, iron, and magnesium oxides depending on source (natural wollastonite vs. synthetic), but these are not present in nutritionally relevant quantities.

Preparation & Dosage

Calcium silicate is applied topically in dental procedures as premixed cements or powders containing 27-50% calcium silicate, with amounts determined by the specific procedure (sufficient to cover pulp or fill root canal). No systemic oral dosages have been studied as this is exclusively used as a dental biomaterial. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Mineral trioxide aggregate (MTA), bioactive glass, hydroxyapatite, calcium hydroxide

Safety & Interactions

Calcium silicate is generally recognized as safe (GRAS) by the FDA as a food additive and anti-caking agent used in table salt and powdered foods at concentrations up to 2%. High systemic calcium intake from calcium silicate supplements may interact with tetracycline antibiotics, fluoroquinolones, and bisphosphonates by chelating these drugs and reducing their bioavailability, so co-administration should be separated by at least 2 hours. Individuals with hypercalcemia, kidney stones, or severe renal impairment should exercise caution, as excess calcium supplementation can exacerbate these conditions. Safety data during pregnancy and lactation for supplemental calcium silicate specifically is insufficient; standard calcium supplementation guidelines (1,000–1,300 mg/day total calcium) should be followed under medical supervision.